Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
18.46
-0.25 (-1.34%)
At close: Mar 28, 2025, 4:00 PM
18.07
-0.39 (-2.11%)
After-hours: Mar 28, 2025, 5:16 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $34.70 million as of March 28, 2025. Its market cap has increased by 269.89% in one year.
Market Cap
34.70M
Enterprise Value
24.68M
1-Year Change
269.89%
Ranking
Category
Stock Price
$18.46
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $34.70M, a decrease of -40.35%. That is a compound annual growth rate of -21.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 34.70M | 34.35% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |